Skip to Content
Merck
CN

T-077

3,3′,5-Triiodo-L-thyronine-13C6 solution

100 μg/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Cerilliant®

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
13C6C9H12I3NO4
CAS Number:
1213431-76-5
Molecular Weight:
656.93
NACRES:
NA.24
UNSPSC Code:
41116107

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1/i3+1,4+1,7+1,10+1,11+1,14+1

InChI key

AUYYCJSJGJYCDS-HRUXDFQWSA-N

SMILES string

IC1=CC(O[13C]2=[13C](I)[13CH]=[13C](C[C@H](N)C(O)=O)[13CH]=[13C]2I)=CC=C1O

grade

certified reference material

form

liquid

feature

(Snap-N-Spike®)

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

100 μg/mL in methanol with 0.1N NH3

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

Quality Level

300

Related Categories

General description

A Certified Spiking Solution® of the internal standard 3,3´,5-Triiodo-L-thyronine-13C6 (T3-13C6). 3,3′,5-Triiodo-L-thyronine or T3 is a thyroid hormone involved with many physiological processes in the human body including growth and development, metabolism, body temperature and heart rate. This internal standard is suitable for quantitation of free and total T3 serum levels by LC-MS/MS for determination of hyperthyroidism caused by excess T3.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

49.5 °F

flash_point_c

9.7 °C

Regulatory Information

危险化学品
This item has

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Christina Stefanaki et al.
The Journal of dermatological treatment, 26(2), 139-142 (2014-05-20)
All available treatments for anogenital warts have substantial failure rates. An immunomodulating treatment that enhances the patient's own immunity could be valuable as an adjuvant to conventional methods. About 123 patients were enrolled in this study and were randomized either
Henry Buchwald et al.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 10(5), 780-786 (2014-05-20)
We do not have a unified, scientifically tested theory of causation for obesity and its co-morbidities, nor do we have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like
Jonathan Kirschner et al.
Emergency radiology, 21(6), 577-581 (2014-05-20)
We sought to determine if CT utilization rates varied by characteristics of the physician. A chart review was performed at an urban academic emergency department (ED) to identify all the CT scans ordered and patients seen for subjects 21 years of
Avantika Gupta et al.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 30(2), 120-125 (2014-05-20)
The aim of this study was to compare the efficacy and safety of intravenous iron sucrose with oral iron therapy in pregnant patients with anemia. The primary outcome of the study was increase in haemoglobin on day 7, 14 &
Nadine Tung et al.
Breast cancer research and treatment, 146(1), 175-182 (2014-05-20)
The majority of breast cancers developing in BRCA1 mutation carriers are triple negative breast cancers (TNBC), an aggressive subtype that accounts for 15-20 % of sporadic breast cancer. We compare the clinical outcome and sites of relapse of TNBC in BRCA1
View All Related Papers

Articles

Simultaneous Determination of Free T3 and Free T4 in Serum

Determination of free thyroid hormones (T3 & T4) in serum by LC-MS/MS following a streamlined 1-hour BioSPME sample preparation.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service